Results 1 to 10 of about 93,945 (299)
Postoperative chemoradiotherapy for gastric cancer
Annals of Oncology, 2003 We report the results of postoperative chemoradiotherapy after curative resection in gastric cancer patients.Patients with gastric cancer staged IB to IV(M0) were treated with chemoradiotherapy after curative resection with extensive (D2) lymph node dissection. Nodal metastases were observed in 261 (90%) patients.
C W Jung, J S Heo, J O Park
exaly +3 more sources
Definitive chemoradiotherapy [PDF]
Journal of Thoracic Disease, 2017 Definitive chemoradiotherapy (dCRT) is reflecting a treatment standard in oesophageal cancer. For irresectable localised tumours and for inoperable patients, dCRT can change the treatment intent from palliative to curative. In patients with squamous cell carcinoma (SCC), in particular in those of cervical location, dCRT is a proper alternative for ...
Stahl, Michael, Budach, Wilfried
openaire +2 more sources
Clinical Observation of Apatinib in Treatment of Refractory Advanced Breast Cancer
Zhongliu Fangzhi Yanjiu, 2020 Objective To evaluate the clinical efficacy and safety of apatinib in the treatment of advanced breast cancer(ABC) patients refractory to multiline treatments.
WANG Jing +5 more
doaj +1 more source
Frontiers in Neurology, 2022 PurposeBreast cancer (BC) is the highest frequent malignancy in women globally. Approximately 25–60% of BC patients with chronic neuropathic pain (CNP) result from advances in treating BC. Since the CNP mechanism is unclear, the various treatment methods
Rui Liu +7 more
doaj +1 more source
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer [PDF]
Cochrane Database of Systematic Reviews, 2013 Please see Appendix 4 for a glossary of terms.The outcome of patients with esophageal cancer is generally poor. Although multimodal therapy is standard, there is conflicting evidence regarding the addition of esophagectomy to chemoradiotherapy.To compare the effectiveness and safety of chemoradiotherapy plus surgery with that of chemoradiotherapy alone
Balamurugan A, Vellayappan +5 more
openaire +2 more sources
PLoS ONE, 2022 IntroductionThe purpose of the current study is to compare definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with cT1-3/N0-3 esophageal squamous cell carcinoma in survival.MethodsRecords from 2008 to 2014 of 4931 ...
Yi-Lin Chang +8 more
doaj +2 more sources
Frontiers in Genetics, 2022 Background: Hepatocellular carcinoma (HCC) is a malignancy with a poor prognosis. This study aimed to distinguish patients with HCC having distinct tumour immune microenvironment (TIME) features and construct an immune-related gene signature (IRGs) to ...
Liangliang Wang +3 more
doaj +1 more source
Identification of prognostic alternative splicing signature in gastric cancer
Archives of Public Health, 2022 Background Aberrant alternative splicing (AS) events could be viewed as prognostic indicators in a large number of malignancies. This study aims to identify prognostic AS events, illuminate the function of the splicing variants biomarkers and provide ...
Zhiwu Wang +4 more
doaj +1 more source
Chemoradiotherapy of esophageal carcinoma [PDF]
Cancer, 1994 Chemoradiotherapy has demonstrated efficacy in esophageal cancer but rarely is curative. To improve local control and decrease metastases, a 7-month regimen was used with standard-dose radiotherapy (RT), cisplatin (DDP), and continuous infusion (CI) 5-fluorouracil (5-FU) in patients with locoregional squamous/adenocarcinoma of the esophagus.Initial ...
E A, Poplin +9 more
openaire +2 more sources
CHEMORADIOTHERAPY FOR COLORECTAL CANCER [PDF]
Gut, 2005 Recent estimates for cancer incidence and mortality in Europe continue to rank colorectal cancer as the second most common cause for cancer related death. Every year more than 376 000 patients are newly diagnosed with colorectal cancer and approximately 200 000 people die from the disease.1 Even though these numbers show a slight decrease,2,3 partially
N, Andre, W, Schmiegel
openaire +2 more sources